Cargando…

The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Objectives: This meta-analysis was conducted to evaluate the effects of hydroxychloroquine (HCQ) in the treatment of primary Sjögren’s syndrome (pSS). Methods: Nine databases were searched for data collection. We used clinical features, including involvement in superficial tissues and visceral syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuan, Zhang, Tongyangzi, Guo, Zizhen, Pu, Jincheng, Riaz, Farooq, Feng, Run, Fang, Xingxing, Song, Jiamin, Liang, Yuanyuan, Wu, Zhenzhen, Pan, Shengnan, Tang, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475756/ https://www.ncbi.nlm.nih.gov/pubmed/34588979 http://dx.doi.org/10.3389/fphar.2021.693796

Ejemplares similares

Effectiveness and Safety of Iguratimod in Treating Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
por: Pu, Jincheng, et al.
Publicado: (2021)

Potential Mechanisms of White Peony against Primary Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking
por: Zhuang, Shuqi, et al.
Publicado: (2022)

Tofacitinib in the treatment of primary Sjögren’s syndrome-associated interstitial lung disease: study protocol for a prospective, randomized, controlled and open-label trial
por: Gao, Ronglin, et al.
Publicado: (2023)

Predicting cardiovascular risk in a Chinese primary Sjögren’s syndrome population: development and assessment of a predictive nomogram
por: Pu, Jincheng, et al.
Publicado: (2023)

Osteoarthritis or arthritis? Toward understanding of primary Sjögren’s syndrome patients with arthralgia
por: Gao, Ronglin, et al.
Publicado: (2023)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Predictors of poor prognosis in ANCA-associated vasculitis (AAV): a single-center prospective study of inpatients in China
por: Gao, Ronglin, et al.
Publicado: (2022)

Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome
por: Yang, Deng-Ho, et al.
Publicado: (2020)

Mesenchymal stem cells negatively regulate CD4(+) T cell activation in patients with primary Sjögren syndrome through the miRNA-125b and miRNA-155 TCR pathway
por: Gong, Bangdong, et al.
Publicado: (2021)

Is hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis
por: Wang, Shi-Qin, et al.
Publicado: (2017)

Hydroxychloroquine-induced Retinal Toxicity
por: Yusuf, Imran H., et al.
Publicado: (2023)

Nontypeable Hemophilus Influenza Meningitis in a Primary Sjögren's Syndrome Patient on Hydroxychloroquine
por: Yassa, Gizem, et al.
Publicado: (2023)

Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis
por: Fang, Yao-Fan, et al.
Publicado: (2017)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
por: Hile, Grace A., et al.
Publicado: (2017)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
por: Monti, Manuela, et al.
Publicado: (2020)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)

The Effectiveness and Safety of Total Glucosides of Paeony in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis
por: Feng, Zhe, et al.
Publicado: (2019)

Therapeutic effect of modified zengye decoction on primary Sjogren’s syndrome and its effect on plasma exosomal proteins
por: Zeng, Yimin, et al.
Publicado: (2022)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review
por: Zhang, Aiping, et al.
Publicado: (2023)

Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method
por: Liu, Qi, et al.
Publicado: (2021)

Systematic review with meta-analysis: Efficacy and safety of biological treatment on salivary gland function in primary Sjögren’s syndrome
por: Wang, Xiaoyan, et al.
Publicado: (2023)

Metabolites Identification of Chemical Constituents From the Eggplant (Solanum melongena L.) Calyx in Rats by UPLC/ESI/qTOF-MS Analysis and Their Cytotoxic Activities
por: Song, Yuanyuan, et al.
Publicado: (2021)

Herbal Formula SS-1 Increases Tear Secretion for Sjögren’s Syndrome
por: Chang, Ching-Mao, et al.
Publicado: (2021)

Ocular microvascular alteration in Sjögren’s syndrome treated with hydroxychloroquine: an OCTA clinical study
por: Yu, Chao, et al.
Publicado: (2023)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
por: Manivannan, Elangovan, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
por: Wu, Qin, et al.
Publicado: (2023)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
por: Kamga Kapchoup, Michelle Vanessa, et al.
Publicado: (2023)

Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome
por: Manzo, Ciro, et al.
Publicado: (2019)

Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2022)

The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
por: Beck, Tyler C., et al.
Publicado: (2020)

Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

Proteomics Analysis of Tears and Saliva From Sjogren’s Syndrome Patients
por: Das, Nabangshu, et al.
Publicado: (2021)

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2023)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
por: Zhang, Miao, et al.
Publicado: (2021)

Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
por: Ren, Lu, et al.
Publicado: (2020)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
por: Chen, Yan, et al.
Publicado: (2020)

Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review
por: Agarwal, Mudit, et al.
Publicado: (2020)

Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
por: Ngai, Jamie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9gk70e5p7e8c8g319b6bjfg6j